p11 regulates extracellular plasmin production and invasiveness of HT1080 fibrosarcoma cells

FASEB Journal

Volumn 17, Issue 2, 2003, Pages 235-246

  Choi, Kyu Sil ^a   Fogg, Darin K ^a   Yoon, Chang Soon ^a   Waisman, David M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Annexin; Cancer; p11; Plasmin; Plasminogen; S100A10; Urokinase

Indexed keywords

BINDING PROTEIN; GENE PRODUCT; PLASMIN; PLASMINOGEN; PROTEIN P11; PROTEINASE; UNCLASSIFIED DRUG; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INVASION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; EXTRACELLULAR MATRIX; FIBROSARCOMA; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; LUNG METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; SCID MOUSE;

ANIMALS; ANNEXIN A2; CALCIUM-BINDING PROTEINS; CELL LINE; CELL MOVEMENT; EXTRACELLULAR SPACE; FIBROSARCOMA; GENETIC VECTORS; HUMANS; MICROSCOPY, FLUORESCENCE; NEOPLASM INVASIVENESS; PLASMIN; PLASMINOGEN ACTIVATORS; RETROVIRIDAE; S100 PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED;

ANIMALIA;

EID: 0037311084     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fj.02-0697com     Document Type: Article

References (39)

1. Andreasen, P. A., Kjoller, L., Christensen, L., and Duffy, M. J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int. J. Cancer 72, 1-22
2. Tapiovaara, H., Alitalo, R., and Vaheri, A. (1996) Plasminogen activation on tumor cell surface and its involvement in human leukemia. Adv. Cancer Res. 69, 101-133
3. Lijnen, H. R., Silence, J., Lemmens, G., Frederix, L., and Collen, D. (1998) Regulation of gelatinase activity in mice with targeted inactivation of components of the plasminogen/plasmin system. Thromb. Haemost. 79, 1171-1176
4. Mazzieri, R., Masiero, L., Zanetta, L., Monea, S., Onisto, M., Garbisa, S., and Mignatti, P. (1997) Control of type IV collagenase activity by components of the urokinase-plasmin system: a regulatory mechanism with cell-bound reactants, EMBO J. 16, 2319-2332
5. Rabbani, S. A., and Mazar, A. P. (2001) The role of the plasminogen activation system in angiogenesis and metastasis. Surg. Oncol. Clin. N. Am. 10, 393-416
6. Mustjoki, S., Alitalo, R., Stephens, R. W., and Vaheri, A. (1999) Plasminogen activation in human leukemia and in normal hematopoietic cells. APMIS 107, 144-149
7. Plow, E. F., Freaney, D. E., Plescia, J., and Miles, L. A. (1986) The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type. J. Cell Biol. 103, 2411-2420
8. Stephens, R. W., Pollanen,J., Tapiovaara, H., Leung, K. C., Sim, P. S., Salonen, E. M., Ronne, E., Behrendt, N., Dano, K., and Vaheri, A. (1989) Activation of pro-urokinase and plasminogen on human sarcoma cells: a proteolytic system with surface-bound reactants. J. Cell Biol. 108, 1987-1995
9. Namiranian, S., Naito, Y., Kakkar, V. V., and Scully, M. F. (1995) Bound plasminogen is rate-limiting for cell-surface-mediated activation of plasminogen by urokinase. Biochem. J. 309, 977-982
10. Felez, J. (1998) Plasminogen binding to cell surfaces. Fibrinolysis Proteolysis 12, 183-189
11. Kassam, G., Le, B. H., Choi, K. S., Kang, H. M., Fitzpatrick, S. L., Louie, P., and Waisman, D. M. (1998) The p11 subunit of the annexin II tetramer plays a key role in the stimulation of t-PA-dependent plasminogen activation. Biochemistry 37, 16958-16966
12. Kassam, G., Choi, K. S., Ghuman, J., Kang, H. M., Fitzpatrick, S. L., Zackson, T., Zackson, S., Toba, M., Shinomiya, A., and Waisman, D. M. (1998) The role of annexin II tetramer in the activation of plasminogen. J. Biol. Chem. 273, 4790-4799
13. Fitzpatrick, S. L., Kassam, G., Choi, K. S., Kang, H.-M., Fogg.D.K., Waisman, D. M. (2000) Regulation of plasmin activity by annexin II tetramer. Biochemistry 39, 1021-1028
14. Hembrough, T. A., Vasudevan, J., Allietta, M. M., Glass, W. F. 2., Gonias, S. L. (1995) A cytokeratin 8-like protein with plasminogen-binding activity is present on the external surfaces of hepatocytes, HepG2 cells and breast carcinoma cell lines. J. Cell Sci. 108, 1071-1082
15. Hembrough, T. A., Li, L., and Gonias, S. L. (1996) Cell-surface cytokeratin 8 is the major plasminogen receptor on breast cancer cells and is required for the accelerated activation of cell-associated plasminogen by tissue-type plasminogen activator. J. Biol. Chem. 271, 25684-25691
16. Kralovich, K. R., Li, L., Hembrough, T. A., Webb, D. J., Karns, L. R., and Gonias, S. L. (1998) Characterization of the binding sites for plasminogen and tissue-type plasminogen activator in cytokeratin 8 and cytokeratin 18. J. Protein Chem. 17, 845-854
17. Hawley, S. B., Tamura, T., and Miles, L. A. (2001) Purification, cloning, and characterization of a profibrinolytic plasminogen-binding protein, TIP49a. J. Biol. Chem. 276, 179-186
18. Miles, L. A., Dahlberg, C. M., Plescia, J., Felez, J., Kato, K., and Plow, E. F. (1991) Role of cell-surface lysines in plasminogen binding to cells: identification of alpha-enolase as a candidate plasminogen receptor. Biochemistry 30, 1682-1691
19. Redlitz, A., and Plow, E. F. (1995) Receptors for plasminogen and t-PA: an update, Baillieres Clin. Haematol. 8, 313-327 (review)
20. Pancholi, V. (2001) Multifunctional alpha-enolase: its role in diseases. Cell. Mol. Life Sci. 58, 902-920
21. Yeatman, T. J., Updyke, T. V., Kaetzel, M. A., Dedman, J. R., and Nicolson, G. L. (1993) Expression of annexins on the surfaces of non-metastatic and metastatic human and rodent tumor cells. Clin. Exp. Metastasis 11, 37-44
22. Mai, J., Finley, R. L., Jr., Waisman, D. M., and Sloane, B. F. (2000) Human procathepsin B interacts with the annexin II tetramer on the surface of tumor cells. J. Biol. Chem. 275, 12806-12812
23. Kang, H. M., Choi, K. S., Kassam, G., Fitzpatrick, S. L., Kwon, M., and Waisman, D. M. (1999) Role of annexin II tetramer in plasminogen activation. Trends Cardiovasc. Med. 9, 92-102
24. Choi, K. S., Fogg, D. K., Fitzpatrick, S. L., and Waisman, D. M. (2002) Role of annexin II tetramer in the regulation of plasmin activity. In Annexins: Biological Importance and Annexin-Related Pathologies (Bandorowicz-Pikula, J., ed) Landes Bioscience, In press
25. Suenson, E., and Thorsen, S. (1988) The course and prerequisites of Lys-plasminogen formation during fibrinolysis. Biochemistry 27, 2435-2443
26. Tibbles, L. A., Spurrell, J. C., Bowen, G. P., Liu, Q., Lam, M., Zaiss, A. K., Robbins, S. M., Hollenberg, M. D., Wickham, T. J., and Muruve, D. A. (2002) Activation of p38 and ERK signaling during adenovirus vector cell entry lead to expression of the C-X-C chemokine IP-10. J. Virol. 76, 1559-1568
27. Laug, W. E., Wang, K., Mundi, R., Rideout, W. 3., Kruithof, E. K., Bogenmann, E. (1992) Clonal variation of expression of the genes coding for plasminogen activators, their inhibitors and the urokinase receptor in HT1080 sarcoma cells. Int. J. Cancer 52, 298-304
28. Mai, J., Waisman, D. M., and Sloane, B. F. (2000) Cell surface complex of cathepsin B/annexin II tetramer in malignant progression. Biochim. Biophys. Acta 1477, 215-230
29. Jones, P. A., Scott-Burden, T., and Gevers, W. (1979) Glycoprotein, elastin, and collagen secretion by rat smooth muscle cells. Proc. Natl. Acad. Sci. USA 76, 353-357
30. DeClerck, Y. A., Imren, S., Montgomery, A. M., Mueller, B. M., Reisfeld, R. A., and Laug, W. E. (1997) Proteases and protease inhibitors in tumor progression. Adv. Exp. Med. Biol. 425, 89-97 (review) (44 refs)
31. Pepper, M. S. (2001) Extracellular proteolysis and angiogenesis. Thromb. Haemost. 86, 346-355
32. Fogg, D. K., Bridges, D. E., Cheung, K. T., Kassam, G., Filipenko, N. R., Choi, K. S., Fitzpatrick, S. L., Nesheim, M., and Waisman, D. M. (2002) The p11 subunit of annexin II heterotetramer is regulated by basic carboxypeptidase. Biochemistry 41, 4953-4961
33. Dano, K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res. 44, 139-266 (review)
34. Cesarman, G. M., Guevara, C. A., and Hajjar, K. A. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator (t-PA). II. Annexin II-mediated enhancement of t-PA-dependent plasminogen activation. J. Biol. Chem. 269, 21198-21203
35. Hajjar, K. A., Jacovina, A. T., and Chacko, J. (1994) An endothelial cell receptor for plasminogen/tissue plasminogen activator. I. Identity with annexin II. J. Biol. Chem. 269, 21191-21197
36. Andronicos, N. M., and Ranson, M. (2001) The topology of plasminogen binding and activation on the surface of human breast cancer cells. Br. J. Cancer 85, 909-916
37. Ellis, V., and Dano, K. (1993) Potentiation of plasminogen activation by an anti-urokinase monoclonal antibody due to ternary complex formation. A mechanistic model for receptor-mediated plasminogen activation. J. Biol. Chem. 268, 4806-4813
38. Ellis, V., Behrendt, N., and Dano, K. (1991) Plasminogen activation by receptor-bound urokinase. A kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266, 12752-12758
39. Ellis, V. (1996) Functional analysis of the cellular receptor for urokinase in plasminogen activation. J. Biol. Chem. 271, 14779-14784